期刊文献+

文拉法辛联合认知行为疗法治疗帕金森抑郁 被引量:7

Venlafaxine combined with cognitive-behavioral therapy in the treatment of depression in Parkinson's disease
下载PDF
导出
摘要 目的研究文拉法辛联合认知行为疗法治疗帕金森抑郁的疗效。方法将70例帕金森抑郁患者随机分为研究组(采用文拉法辛联合认知行为疗法治疗)和对照组(单用文拉法辛治疗),各35例,于治疗前及治疗后第4、8周末采用汉密顿抑郁量表(HAMD,17项)评定抑郁程度。结果两组治疗4、8周后HAMD评分均低于治疗前(P<0.05),第4、8周末,研究组的HAMD均低于同期对照组,差异均有统计学意义(P<0.05)。结论文拉法辛联合认知行为疗法治疗帕金森抑郁疗效确切,比单用文拉法辛治疗效果更好。 Objective To determine whether Venlafaxinc combined with cognitive-behavioral therapy (CBT) is effective in the treatment of depression in Parkinson's disease (PD). Methods A total of 70 patients with PD were randomly assigned into the study group(treated by venlafaxine combined with CBT) and the control group (treated with venlafaxine alone). Before treatment and on the forth and eighth weekend after treatment, Hamilton Depression Scale (HAMD, 17 items) was used to evaluate the degree of depression. Results On the forth and eighth weekend after the treatment, the mean HAMD in the two groups were significantly lower than those before treatment (P〈0.05), and the HAMD was significantly lower in the study group than those in the control group (P〈0.05). Conclusion Vcnlafaxinc combined with CBT is more effective than venlafaxine alone in the treatment of delaression in Parkinson's disease.
出处 《海南医学》 CAS 2011年第17期37-38,共2页 Hainan Medical Journal
关键词 文拉法辛 认知行为疗法 帕金森 抑郁 Venlafaxine Cognitive-behavioral therapy (CBT) Parkinson's disease (PD) Depression
  • 相关文献

参考文献3

  • 1Baronc P. Treatment of depressive symptoms in Parkinson's disease [J]. Eur J Neurol, 2011, 18 (Suppl1): 11-15. 被引量:1
  • 2Dobkin RD, Mcnza M, Bienfait KL, et al. The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's disease [J]. J Neuropsychiatry Clin Neurosei, 2010, 22 (2): 188-195. 被引量:1
  • 3Farabaugh A, Locascio JJ, Yap L, et al. Cognitive-behavioral therapy for patients with Parkinson's disease and cornorbid major depressive disorder [J]. Psych Psychosomafics, 2010, 51(2): 124-129. 被引量:1

同被引文献73

  • 1武力勇,贾建平.普拉克索的临床应用及安全性[J].药物不良反应杂志,2007,9(2):77-80. 被引量:20
  • 2Hostetter DR,Loeb CR,Chu F,et al.Hip is a pro-survival substrate of granzyme B [J].J Biol Chem,2007,282(38):27865-27874. 被引量:1
  • 3Hwang JR,Zhang C,Patterson C.C-terminus of heatshock protein 70-interacting protein facilitatesdegradation of apoptosis signal-regu-lating kinase 1 andinhibits apoptosis signal-regulating kinase 1-dep-endentapopto:sis[J].Cell Stress Chaperones,2005,10(2):147-156. 被引量:1
  • 4Odutayo 0.Odunuga,Judith A.Homby,et al.Tetratr-icopeptide Repeat Motif-mediated Hsc70-mSTIlInteractionfJ].J.BIO.CHEM,2003,(9):6896-6904. 被引量:1
  • 5Sharp,S.and Workman,P.Inhibitors of the HSP90molecular chaperone:current status [J].Adv.Cancer Res,2006,(95):323-348. 被引量:1
  • 6Olanow CW,Stern MB,Sethi K.The scientific and clinical basis for the treatment ofParkinson disease[J].Neurology,2009;72(21):130-136. 被引量:1
  • 7Tanei T5Kajita YiNihashi T,et al.Changes in regional bloodflow induced byunilateral subthalamic nucleus stimulation in patients with Parkinson's disease[J].Neurol Med Chir(Tokyo).2009;49(11):507-513. 被引量:1
  • 8Barone P.Treatmcnt of depressive symptoms in Parkinson's disease[J].Eur JNeurol,201 l;18(SuppI):l 1-15. 被引量:1
  • 9Dobkin RD,Mcnza M,Bienfait K.L,et al.The impact of antidepressant treatmenton cognitive functioning in depressed patients with Parkinson's disease[J].JNeuropsychiatry Clin Neurosci,2010;22(2):188-195. 被引量:1
  • 10陈海波,王新德.统一帕金森病评定量表[J].中华老年医学杂志,1999,18(1):61-62. 被引量:12

引证文献7

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部